Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica

Acta Neuropathologica

Volumn 134, Issue 1, 2017, Pages 35-44

  Tradtrantip, Lukmanee ^a   Yao, Xiaoming ^a   Su, Tao ^a   Smith, Alex J ^a   Verkman, Alan S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aquaporin 4; Astrocyte; Complement dependent cytotoxicity; NMO; Oligodendrocyte

Indexed keywords

AQUAPORIN 4 ANTIBODY; COMPLEMENT COMPONENT C3D; COMPLEMENT MEMBRANE ATTACK COMPLEX; IMMUNOGLOBULIN G ANTIBODY; AQUAPORIN 4; AUTOANTIBODY; COMPLEMENT; IMMUNOGLOBULIN G; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; ASTROCYTE; COCULTURE; COMPLEMENT ACTIVATION; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT DEPENDENT CYTOTOXICITY; DEMYELINATION; MYELOOPTIC NEUROPATHY; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROCYTE CULTURE; OLIGODENDROCYTE PROGENITOR; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN BINDING; RAT; ANIMAL; BRAIN; BYSTANDER EFFECT; CELL CULTURE; DISEASE MODEL; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; TRANSGENIC RAT;

ANIMALS; AQUAPORIN 4; ASTROCYTES; AUTOANTIBODIES; BRAIN; BYSTANDER EFFECT; CELLS, CULTURED; COCULTURE TECHNIQUES; COMPLEMENT SYSTEM PROTEINS; DISEASE MODELS, ANIMAL; IMMUNOGLOBULIN G; NEUROMYELITIS OPTICA; OLIGODENDROGLIA; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; RECOMBINANT PROTEINS;

EID: 85020066426     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-017-1734-6     Document Type: Article

References (41)

1. Asavapanumas N, Ratelade J, Verkman AS (2014) Unique neuromyelitis optica pathology produced in naive rats by intracerebral administration of NMO-IgG. Acta Neuropathol 127:539–551
2. Asgari N, Khorooshi R, Lillevang ST, Owens T (2013) Complement-dependent pathogenicity of brain-specific antibodies in cerebrospinal fluid. J Neuroimmunol 254:76–82
3. Bennett JL, Lam C, Kalluri SR, Saikali P, Bautista K, Dupree C, Glogowska M, Case D, Antel JP, Owens GP, Gilden D, Nessler S, Stadelmann C, Hemmer B (2009) Intrathecal pathogenic anti–aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 66:617–629
4. Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, Reindl M, Adzemovic M, Bauer J, Berger T, Fujihara K, Itoyama Y, Lassmann H (2009) Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol 66:630–643
5. Brown DR, Kretzschmar HA (1998) The glio-toxic mechanism of α-aminoadipic acid on cultured astrocytes. J Neurocytol 27:109–118
6. Crane JM, Lam C, Rossi A, Gupta T, Bennett JL, Verkman AS (2011) Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1/M23 isoforms and orthogonal arrays. J Biol Chem 286:16516–16524
7. Dincman TA, Beare JE, Ohri SS, Whittemore SR (2012) Isolation of cortical mouse oligodendrocyte precursor cells. J Neurosci Methods 209:219–226
8. Gotze O, Muller-Eberhard HJ (1970) Lysis of erythrocytes by complement in the absence of antibody. J Exp Med 132:898–915
9. Hinson SR, Roemer SF, Lucchinetti CF, Fryer JP, Kryzer TJ, Chamberlain JL, Howe CL, Pittock SJ, Lennon VA (2008) Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med 205:2473–2481
10. Hinson SR, Romero MF, Popescu BF, Lucchinetti CF, Fryer JP, Wolburg H, Fallier-Becker P, Noell S, Lennon VA (2012) Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes. Proc Natl Acad Sci USA 109:1245–1250
11. Huck S, Grass F, Hortnagl H (1984) The glutamate analog α-aminoadipic acid is taken up by astrocytes before exerting its gliotoxic effect in vitro. J Neurosci 4:2650–2657
12. Jarius S, Wildemann B (2010) AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol 6:383–392
13. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473–477
14. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H (2002) A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Brain 125:1450–1461
15. Marignier R, Nicolle A, Watrin C, Touret M, Cavagna S, Varrin-Doyer M, Cavillon G, Rogemond V, Confavreux C, Honnorat J, Giraudon P (2010) Oligodendrocytes are damages by neuromyelitis optic immunoglobulin G via astrocyte injury. Brain 133:2578–2591
16. Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, Takahashi T, Nakashima I, Takahashi H, Itoyama Y (2007) Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 130:1224–1234
17. Papadopoulos MC, Verkman AS (2012) Aquaporin 4 and neuromyelitis optica. Lancet Neurol 11:535–544
18. Park CC, Shin ML, Simard JM (1997) The complement membrane attack complex and the bystander effect in cerebral vasospasm. J Neurosurg 87:294–300
19. Parratt JD, Prineas JW (2010) Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of a perivascular astrocytes. Mult Scler 16:1156–1172
20. Phuan PW, Ratelade J, Rossi A, Tradtrantip L, Verkman AS (2012) Complement-dependent cytotoxicity in neuromyelitis optica requires aquaporin-4 protein assembly in orthogonal arrays. J Biol Chem 287:13829–13839
21. Piddlesden SJ, Morgan BP (1993) Killing of rat glial cells by complement: deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis. J Neuroimmunol 48:169–175
22. Ratelade J, Asavapanumas N, Ritchie AM, Wemlinger S, Bennett JL, Verkman AS (2013) Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica. Acta Neuropathol 126:699–709
23. Ratelade J, Bennett JL, Verkman AS (2011) Evidence against cellular internalization in vivo of NMO-IgG, aquaporin-4, and excitatory amino acid transporter 2 in neuromyelitis optica. J Biol Chem 286:45156–45164
24. Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF (2007) Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130:1194–1205
25. Rossi A, Ratelade J, Papadopoulos MC, Bennett JL, Verkman AS (2012) Neuromyelitis optica IgG does not alter aquaporin-4 water permeability, plasma membrane M1/M23 isoform content or supramolecular assembly. Glia 60:2027–2039
26. Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC (2010) Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 133:349–361
27. Sagan SA, Winger RC, Cruz-Herranz A, Nelson PA, Hagberg S, Miller CN, Spencer CM, Ho PP, Bennette JL, Levy M, Levin MH, Verkman AS, Stienman L, Green AJ, Anderson MS, Sobel RA, Zamvil SS (2016) Tolerance checkpoint bypass permits emergence of pathogenic T cells to neuromyelitis optica autoantigen aquaporin-4. Proc Natl Acad Sci USA 113:14781–14786
28. Scolding NJ, Morgan BP, Compston DA (1998) The expression of complement regulatory proteins by adult human oligodendrocytes. J Neuroimmunol 84:69–75
29. Smith AJ, Jin BJ, Ratelade J, Verkman AS (2014) Aggregation state determines the localization and function of M1- and M23-aquaporin-4 in astrocytes. J Cell Biol 204:559–573
30. Smith AJ, Verkman AS (2015) Superresolution imaging of aquaporin-4 cluster size in antibody-stained paraffin brain sections. Biophys J 109:2511–2522
31. Tradtrantip L, Asavapanumas N, Verkman AS (2013) Therapeutic cleavage of anti-aquaporin-4 autoantibody in neuromyelitis optica by an IgG-selective proteinase. Mol Pharmacol 83:1268–1275
32. Tradtrantip L, Ratelade J, Zhang H, Verkman AS (2013) Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody. Ann Neurol 73:77–85
33. Tradtrantip L, Zhang H, Saadoun S, Phuan PW, Lam C, Papadopoulos MC, Bennett JL, Verkman AS (2012) Anti–aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica. Ann Neurol 71:314–322
34. Tradtrantip L, Zhang H, Anderson MO, Saadoun S, Phuan PW, Papadopoulos MC, Bennett JL, Verkman AS (2012) Small-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica. FASEB J 26:2197–2208
35. Waxman SG, Black JA (1984) Freeze-fracture ultrastructure of the perinodal astrocyte and associated glial junctions. Brain Res 308:77–87
36. Whitney KD, McNamara JO (2000) GluR3 autoantibodies destroy neural cells in a complement dependent manner modulated by complement regulatory proteins. J Neurosci 20:7307–7316
37. Wing MG, Zajicek J, Seilly DJ, Compston DA, Lachmann PJ (1992) Oligodendrocytes lack glycolipid anchored proteins which protect them against complement lysis. Restoration of resistance to lysis by incorporation of CD59. Immunology 76:140–145
38. Wolburg H, Wolburg-Buchholz K, Fallier-Becker P, Noell S, Mack AF (2011) Structure and functions of aquaporin-4-based orthogonal arrays of particles. Int Rev Cell Mol Biol 287:1–41
39. Wrzos C, Winkler A, Metz I, Kayser DM, Thal DR, Wegner C, Bruck W, Nessler S, Bennett JL, Stadelmann C (2014) Early loss of oligodendrocytes in human and experimental neuromyelitis optic lesions. Acta Neuropathol 127:523–538
40. Yao X, Su T, Verkman AS (2016) Clobetasol promotes remyelination in a mouse model of neuromyelitis optica. Acta Neuropathol Commun 4:42
41. Zipfel PF, Skerka C (2009) Complement regulators and inhibitory proteins. Nat Rev Immunol 9:729–740